MedTrace Logo

Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder

NCT06600529 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-09-19

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the efficacy of a combination of photo-biomodulation at acupuncture points, autologous platelet-rich plasma (PRP), and umbilical cord-derived exosome therapy in children with Autism Spectrum Disorder (ASD). The study will compare these interventions against standard care to determine their impact on the severity of autism symptoms, as measured by the Childhood Autism Rating Scale (CARS) and other related markers.

Conditions

Interventions

DEVICE

Photo-Biomodulation

Application at acupuncture points for 20 seconds each week. using 810nm Laser probe

BIOLOGICAL

Autologous PRP

IV injection of Autologous Plasma Rich Platelets (PRP) on Days 0, 15, 30, and 45.

BIOLOGICAL

Exosome Therapy

IV injection of Umbilical Cord-Derived Exosomes at laser acupuncture points Umbilical Cord-Derived Exosomes

OTHER

Standard Care (in control arm)

Routine conventional including Applied Behavioral Analysis (ABA) for Autism Spectrum Disorder (ASD)

Sponsors & Collaborators

  • Iffat Anwar Medical Complex

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-13
Primary Completion
2025-06-10
Completion
2025-12-13

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06600529 on ClinicalTrials.gov